Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01417546
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:26.948004+00:00
Published At
2021-10-18T00:00:00+00:00
Record Updated At
2021-10-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Epithelial Neoplasms, Malignant", "Epithelial Tumors, Malignant", "Malignant Mesenchymal Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-10-18"
protocolSection.identificationModule.nctId
"NCT01417546"
protocolSection.identificationModule.officialTitle
"First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Epithelial Neoplasms, Malignant (protocolSection.conditionsModule.conditions)
  • Epithelial Tumors, Malignant (protocolSection.conditionsModule.conditions)
  • Malignant Mesenchymal Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.